INS and Hyperglycemia: The basal–bolus insulin therapy regimen remains a useful treatment for many inpatients, especially those with symptomatic hyperglycemia, poor glycemic control prior to admission, and those who fail to maintain glucose control with basal insulin, plus DPP4-i.